Ex Parte Al-TerkiDownload PDFPatent Trial and Appeal BoardMar 30, 201813784719 (P.T.A.B. Mar. 30, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. 13/784,719 37833 7590 Richard C. Litman FILING DATE 03/04/2013 04/03/2018 112 S. West Street Alexandria, VA 22314 FIRST NAMED INVENTOR ABDULMOHSEN E.A.H. AL-TERKI UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 32600.81 2135 EXAMINER PENG, BO JOSEPH ART UNIT PAPER NUMBER 3786 NOTIFICATION DATE DELIVERY MODE 04/03/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): uspto@4patent.com uspto@nathlaw.com mbashah@nathlaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ABDULMOHSEN E.A.H. AL-TERKI Appeal2016-000352 Application 13/784,719 Technology Center 3700 Before CHARLES N. GREENHUT, ANNETTE R. REIMERS, and PAUL J. KORNICZKY, Administrative Patent Judges. REIMERS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Abduhnohsen E.A.H. Al-Terki (Appellant) appeals appeal under 35 U.S.C. § 134(a) from the Examiner's decision to reject claims 6-10. Claims 1-5 and 11-15 have been canceled. We have jurisdiction under 35 U.S.C. § 6(b ). We REVERSE. Appeal 2016-000352 Application 13/784,719 CLAIMED SUBJECT MATTER The claimed subject matter relates to "a multiple oral and nasal surgical procedure[]." Spec. i12, Figs. 10, 11. Claim 6, the sole independent claim on appeal, is representative of the claimed subject matter and recites: 6. A method of evaluating the oral and nasal organs of a person having obstructive sleep apnea, comprising the steps of: (a) performing a nasal endoscopy of the person; (b) performing a computerized tomography scan of the sinuses of the person; ( c) performing a sleep study of the person; ( d) performing a sleep endoscopy of the person; ( e) performing a quantitative evaluation of the left and right frontal sinuses in accordance with the findings of steps (a) through (d); (t) recording the results of the frontal sinus evaluation as a value; (g) performing a quantitative evaluation of the left and right ethmoid sinuses in accordance with the findings of steps (a) through (d); (g) recording the results of the ethmoid sinus evaluation as a value; (i) performing a quantitative evaluation of the left and right maxillary sinuses in accordance with the findings of steps (a) through (d); (j) recording the results of the maxillary sinus evaluation as a value; (k) performing a quantitative evaluation of the left and right sphenoid sinuses in accordance with the findings of steps (a) through (d); (1) recording the results of the sphenoid sinus evaluation as a value; (m) performing a quantitative evaluation of the nasal septum in accordance with the findings of steps (a) through (d); (n) recording the results of the nasal septum evaluation as a value; 2 Appeal 2016-000352 Application 13/784,719 ( o) performing a quantitative evaluation for nasal polyps in accordance with the findings of steps (a) through (d); (p) recording the results of the nasal polyp evaluation as a value; ( q) performing a quantitative evaluation of the nasal valve in accordance with the findings of steps (a) through (d); (r) recording the results of the nasal valve evaluation as a value; ( s) performing a quantitative evaluation of the left and right inferior nasal turbinates in accordance with the findings of steps (a) through (d); (t) recording the results of the inferior nasal turbinate evaluation as a value; (u) performing a quantitative evaluation of the left and right middle nasal turbinates in accordance with the findings of steps (a) through (d); ( v) recording the results of the middle nasal turbinate evaluation as a value; (w) adding the quantitative values for the sinonasal evaluations of steps ( e) through ( v ); (x) performing a visual examination of the tonsils; (y) performing a quantitative evaluation of the tonsils in accordance with the findings of the visual examination of step (x); value; (z) recording the results of the tonsil evaluation as a (aa) adding the quantitative values of steps (w) and (z); (bb) performing a nasal endoscopy of the adenoids; (cc) performing a quantitative evaluation of the adenoids in accordance with the findings of the nasal endoscopy of step (bb); ( dd) recording the results of the adenoid evaluation as a value; (ee) adding the quantitative values of steps (aa) and (dd); (ff) performing a visual examination of the tongue base, epiglottis, and lateral pharyngeal walls; (gg) performing a quantitative evaluation of the tongue base in accordance with the findings of the visual examination of step (dd); 3 Appeal 2016-000352 Application 13/784,719 (hh) recording the results of the tongue base evaluation as a value; (ii) performing a quantitative evaluation of the epiglottis in accordance with the findings of the visual examination of step (ft); (jj) recording the results of the epiglottis evaluation as a value; (kk) performing a quantitative evaluation of the lateral pharyngeal walls in accordance with the findings of the visual examination of step (ft); (ll) recording the results of the lateral pharyngeal wall evaluation as a value; (ll); (mm) adding the quantitative values of steps (hh), (jj), and (nn) adding the quantitative values of steps ( ee) and (mm); ( oo) performing a visual examination of the soft palate; (pp) performing a quantitative evaluation of the soft palate in accordance with the findings of the examinations of steps ( c ), (d), and (oo); ( qq) recording the results of the soft palate evaluation as a value; (rr) adding the quantitative values of steps (nn) and (qq), thereby arriving at a total score; and (ss) determining the appropriate obstructive sleep apnea treatment for the person, from the quantitative values determined. REJECTIONS I. Claims 6 and 8 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Makower (US 2005/0240147 Al, published Oct. 27, 2005), Doelling (US 2011/0295083 Al, published Dec. 1, 2011), van der Burg (US 2008/0027480 Al, published Jan. 31, 2008), Underwood (US 2005/0234439 Al, published Oct. 20, 2005), Moore (US 2007/0239056 Al, published Oct. 11, 2007), Mechlenburg (US 2006/0112959 Al, published June 1, 2006), Rowlandson (US 2005/0234313 Al, published Oct. 20, 4 Appeal 2016-000352 Application 13/784,719 2005), Cahali 1 and Injury '2001. 2 II. Claim 7 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Makower, Doelling, van der Burg, Underwood, Moore, Mechlenburg, Rowlandson, Cahali, Injury '2001, and Richardson. 3 III. Claim 9 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Makower, Doelling, van der Burg, Underwood, Moore, Mechlenburg, Rowlandson, Richardson, Cahali, Injury '2001, Richardson, Zucconi, 4 and Chan. 5 IV. Claim 10 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Makower, Doelling, van der Burg, Underwood, Moore, Mechlenburg, Rowlandson, Richardson, Cahali, Injury '2001, and Westbrook (US 2002/0165462 Al, published Nov. 7, 2002) 1 Cahali et al., Tonsil volume, tonsil grade and obstructive sleep apnea: is there any meaningful correlation? 66 CLINICS 1347-1351 (2011) (hereinafter "Cahali"). 2 Injury Severity Scoring (http://www.surgicalcriticalcare.netiResources /iniury severity scoring.pdf, pages 1-12, 05/29/2001 (hereinafter "Injury '2001 "). 3 Richardson et al., Protocol for the Examination of Specimens from Patients with Carcinomas of the Lip and Oral Cavity AJCC/UICC TNM, 7th edition, web posting date: Oct 2009 (hereinafter "Richardson"). 4 Zucconi et al., Habitual snoring with and without obstructive sleep apnoea: the importance of cephalometric variables 47 Thorax 157-161 (1992) (hereinafter "Zucconi"). 5 Chan et al., Obstructive Sleep Apnea in Children 69 Am Fam Physician 1147-54, 1159-60 (2004) (hereinafter "Chan"). 5 Appeal 2016-000352 Application 13/784,719 Claims 6 and 8 ANALYSIS Rejection I Appellant contends "[ t ]he Examiner states that the base reference to Makower possesses quantitative evaluations ... as disclosed in paragraphs ... , [0021] [and] [0131]. However, [neither] oftheseparagraphshave [the] disclosure as stated by the Examiner." Appeal Br. 10;6 see also Reply Br. 2; 7 Non-Final Act. 3--4; 8 Ans. 15. 9 Appellant's argument is persuasive. Paragraph 21 ofMakower merely discusses "Reduction/Removal of Nasal Turbinates." See Makower i-fi-120, 21. Paragraph 131 of Makower merely describes the anatomy of the human nose. See Makower i-f 131. Neither of these paragraphs discusses an "evaluation" of any kind let alone a "quantitative evaluation" of various organs, as called for in claim 6. In response to Appellant's contention, the Examiner states that "[a]ny diagnostic images of the left and right frontal sinuses are a quantitative evaluation while recorded as imaging because any diagnostic image is made of the contrast of different tissues (i.e. a certain contrast ratio) and boundary or outline of different tissue (i.e. SNR of the image)." Ans. 15. However, the Examiner fails to adequately explain how "contrast of different tissues" (i.e., the light and dark areas of a diagnostic image) correlates to a 6 Appeal Brief (hereinafter "Appeal Br.") (filed Sept. 29, 2014). 7 Reply Brief (hereinafter "Reply Br.") (filed Oct. 5, 2015). 8 Non-Final Office Action (hereinafter "Non-Final Act.") (mailed Apr. 4, 2014). 9 Examiner's Answer (hereinafter "Ans.") (mailed Aug. 18, 2015). 6 Appeal 2016-000352 Application 13/784,719 "quantitative/numeric" evaluation of various organs. See Ans. 15; see also Reply Br. 4 ("It is unclear how diagnostic images can be added together, as can the instantly claimed scores from a quantitative evaluation."). 10 Accordingly, for the foregoing reasons, we do not sustain the Examiner's rejection of claims 6 and 8 as unpatentable over Makower, Doelling, van der Burg, Underwood, Moore, Mechlenburg, Rowlandson, Cahali, and Injury '2001. Rejections II-IV Claims 7, 9, and 10 The Examiner's obviousness rejections of claims 7, 9, and 10 are each based on the same unsupported findings discussed above with respect to independent claim 6. See Final Act. 8-11. The Examiner does not rely on Richardson, Zucconi, Chan, or Westbrook to remedy the deficiency of Makower. Accordingly, for reasons similar to those discussed above for claim 6, we do not sustain the Examiner's obviousness rejections of claims 7, 9, and 10. 10 Appellant's Specification describes that "[ e Jach of the letters of the mnemonic ST ATS is assigned a numerical value in accordance with the point value or score [i.e., the quantitative evaluation] determined during the examination of the patient" and "[ t ]he results of the examination of each area, organ, or organ group are recorded quantitatively, i.e., as either a zero (indicating normal structure and function, no correction is needed) or one (indicating that some form of correction is needed). The results are recorded in the STATS format described further above." Spec. i-fi-165, 66, respectively (emphasis added). 7 Appeal 2016-000352 Application 13/784,719 DECISION We REVERSE the decision of the Examiner to reject claims 6-10. REVERSED 8 Copy with citationCopy as parenthetical citation